Uric acid as a cross-over between rheumatology and cardiovascular disease

被引：7

作者：

Borghi, Claudio ^{[1
]}

机构：

[1] Univ Bologna, St Orsola Malpighi Hosp, Bologna, Italy

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2013年 / 29卷

关键词：

Cardiovascular disease; Gout; Rheumatology; Uric acid; GOUT;

D O I：

10.1185/03007995.2013.795141

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1 / 2

页数：2

共 6 条

[1]

Uric acid and cardiovascular risk [J].

Feig, Daniel I. ;

Kang, Duk-Hee ;

Johnson, Richard J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1811-1821

[2]

Garcia-Valladares I, 2011, THER ADV MUSCULOSKEL, V3, P245

[3]

Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis [J].

Higgins, Peter ;

Dawson, Jesse ;

Lees, Kennedy R. ;

McArthur, Kate ;

Quinn, Terrence J. ;

Walters, Matthew R. .

CARDIOVASCULAR THERAPEUTICS, 2012, 30 (04) :217-226

[4]

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? [J].

Johnson, RJ ;

Kang, DH ;

Feig, D ;

Kivlighn, S ;

Kanellis, J ;

Watanabe, S ;

Tuttle, KR ;

Rodriguez-Iturbe, B ;

Herrera-Acosta, J ;

Mazzali, M .

HYPERTENSION, 2003, 41 (06) :1183-1190

[5]

Treating to target: a strategy to cure gout [J].

Perez-Ruiz, Fernando .

RHEUMATOLOGY, 2009, 48 :9-14

[6]

Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial [J].

Schumacher, H. Ralph, Jr. ;

Becker, Michael A. ;

Wortmann, Robert L. ;

MacDonald, Patricia A. ;

Hunt, Barbara ;

Streit, Janet ;

Lademacher, Christopher ;

Joseph-Ridge, Nancy .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (11) :1540-1548

← 1 →